CASI Pharmaceuticals, Inc. (CASIF) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $20.71M | -27.4% |
| 2024 | $28.54M | -15.8% |
| 2023 | $33.88M | -21.4% |
| 2022 | $43.11M | +42.9% |
| 2021 | $30.17M | +99.2% |
| 2020 | $15.14M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $20.71M | -27.4% |
| 2024 | $28.54M | -15.8% |
| 2023 | $33.88M | -21.4% |
| 2022 | $43.11M | +42.9% |
| 2021 | $30.17M | +99.2% |
| 2020 | $15.14M | — |